Defend the World Health Organization from corporate takeoverContra a influência corporativa na OMS

See also http://www.phmovement.org/en/node/9980 PHM, IBFAN, TWN Press Release Defend the World Health Organization from corporate takeover Geneva, 19 May 2015 – Ahead of the first meeting of the drafting group on Framework for Engagement with Non – State Actors (FENSA), Civil Society Organisations and Social Movements expressed their deep concern on attempts to facilitate corporate […]

Assinamos a carta à CCJC pela reforma da lei de patentes

To: Representative Arthur Lima President of the Commission on Constitution, Justice and Citizenship – CCJC Brazilian National Congress – House of Representatives (dep.arthurlira@camara.leg.br)     Ref.: Bill 139/1999 – patent law reform Regarding nomination of the rapporteur   Most Illustrious Representative,   Several on-going bills at the House of Representatives of the Brazilian National Congress […]

Reuniões no Rio de Janeiro e Washington, DC

As últimas semanas foram repletas de importantes desenvolvimentos para a UAEM, tanto no Brasil quanto internacionalmente. Nos dias 21 e 22 de Janeiro, a UAEM Brasil realizou a 1ª Reunião do Conselho Consultivo e a sua 2ª Reunião Anual. Logo depois, entre os dias 6 e 9 de fevereiro, a UAEM Norte-americana congregou seu Comitê […]

Recent developments of the Brazilian patent law reformDesenvolvimentos recentes da reforma da lei de patentes

With the new legislature coming into place, some bills that were being discussed in the Brazilian Parliament were automatically archived. One of such was PL 5.402/13, related to the patent law reform. Representative Jandira Feghali (PCdoB) required it be unarchived, along with all bills referring to the patent law reform. This reopens the debate on the subject, […]

UAEM Brazil signs civil society letter on new EU’s legislation for trademark A UAEM Brasil assina carta sobre regras propostas para a legislação de marcas da UE

A União Européia havia alterado sua legislação para permitir a passagem de medicamentos genéricos depois de ser denunciada na OMC por apreensões indevidas destes bens. Nos últimos meses uma nova legislação, que possui os mesmos vícios da anterior, vem sendo discutida no âmbito da EU e pode colocar em risco o abastecimento mundial de genéricos […]

UAEM Brasil signs civil society letter to the indian IPR Think TankA UAEM Brasil assina a carta da sociedade civil ao IPR Think Tank indianoUAEM Brasil firma la carta de la sociedad civil al IPR Think Tank

The recently formed IPR Think Tank will have the task of identifying good practices and strategic policy spaces for intellectual property in India. Civil society groups have written, and organizations of the global access to medicines and health community endorse, a letter to the think tank requesting that India’s leading role in the developing world […]

Follow-up on the event with Ellen ‘t Hoen at FGVComo foi o evento com Ellen ‘t Hoen na FGVRecibimos Ellen ‘t Hoen en FGV

On 08 October, UAEM Brazil and the Centre for Technology and Society at the Law School of the Getulio Vargas Foundation (CTS / FGV) organized the event “Patents and access to medicines: alternative models of funding for Research and Development“. Third in a series on the topic at FGV, the guest speaker this time was […]

In sickness and in wealth: intellectual property, development and access to medicinesNa doença e na riqueza: propriedade industrial, desenvolvimento e acesso a medicamentosEn la enfermedad y en la abundancia: propiedad intelectual, desarrollo y acceso a medicamentos

On September 4, 2014, UAEM Brazil organized in its FGV chapter, in partnership with the Centre for Technology and Society of the FGV Law School, the event ” In Sickness and in Wealth: industrial property, development and access to medicines ” .The table was composed of Valbona Muzaka, member of the European and International Studies […]

Acesso a Medicamentos em Portugal

post da convidada Eva Fernandes, Quinto ano do Mestrado Integrado em Ciências Farmacêuticas da Faculdade de Farmácia da Universidade do Porto Segundo a OMS (Organização Mundial de Saúde), para alcançar o melhor nível de saúde é necessário que exista igualdade no acesso a fármacos que sejam seguros e económicos[1]. De acordo com “Análise comparativa do […]